Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-01-14 09:02 am Purchase |
2021-01-10 | 13G | Applied DNA Sciences, Inc. APDN |
Empery Asset Management, LP | 480 6.420% |
473 (+6880.80%) |
Filing History |
| 2021-01-14 09:00 am Purchase |
2021-01-08 | 13G | Zevra Therapeutics, Inc. ZVRA |
Empery Asset Management, LP | 1,230,000 9.990% |
1,230,000 (New Position) |
Filing History |
| 2021-01-14 09:00 am Purchase |
2021-01-06 | 13G | Atossa Therapeutics, Inc. ATOS |
Empery Asset Management, LP | 4,760,500 5.320% |
4,760,500 (New Position) |
Filing History |
| 2021-01-13 09:03 am Purchase |
2020-12-31 | 13G | Castor Maritime Inc. CTRM |
Empery Asset Management, LP | 277,333 9.910% |
130,000 (+88.24%) |
Filing History |
| 2021-01-13 09:03 am Sale |
2020-12-31 | 13G | CELLECT BIOTECHNOLOGY LTD SPON APOP |
Empery Asset Management, LP | 185,200 0.050% |
-32,114,800 (-99.43%) |
Filing History |
| 2021-01-13 09:02 am Sale |
2020-12-31 | 13G | Allena Pharmaceuticals, Inc. ALNAQ |
Empery Asset Management, LP | 0 0.000% |
-2,792,683 (Position Closed) |
Filing History |
| 2021-01-13 09:02 am Unchanged |
2020-12-31 | 13G | Artelo Biosciences, Inc. ARTL |
Empery Asset Management, LP | 61,333 4.990% |
0 (Unchanged) |
Filing History |
| 2021-01-13 09:01 am Sale |
2020-12-31 | 13G | Baudax Bio, Inc. BXRX |
Empery Asset Management, LP | 714 2.600% |
-1,374 (-65.79%) |
Filing History |
| 2021-01-13 09:01 am Purchase |
2020-12-31 | 13G | Nuwellis, Inc. NUWE |
Empery Asset Management, LP | 137 4.990% |
137 (New Position) |
Filing History |
| 2021-01-13 09:00 am Sale |
2020-12-31 | 13G | Aethlon Medical, Inc. AEMD |
Empery Asset Management, LP | 82,502 4.990% |
-21,587 (-20.74%) |
Filing History |
| 2021-01-07 12:47 pm Purchase |
2020-12-31 | 13G | Orbital Infrastructure Group, Inc. OIG |
Empery Asset Management, LP | 46,296 5.110% |
46,296 (New Position) |
Filing History |
| 2020-12-08 09:40 am Purchase |
2020-12-02 | 13G | Envirotech Vehicles, Inc. ADOM |
Empery Asset Management, LP | 6,250,005 6.180% |
6,250,005 (New Position) |
Filing History |
| 2020-12-02 11:12 am Purchase |
2020-11-25 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
Empery Asset Management, LP | 2,000 6.910% |
2,000 (New Position) |
Filing History |
| 2020-11-18 10:08 am Purchase |
2020-11-12 | 13G | InMed Pharmaceuticals Inc. INM |
Empery Asset Management, LP | 44 6.350% |
44 (New Position) |
Filing History |
| 2020-11-12 10:38 am Purchase |
2020-11-05 | 13G | Opus Genetics, Inc. IRD |
Empery Asset Management, LP | 591,016 8.330% |
591,016 (New Position) |
Filing History |
| 2020-11-02 12:09 pm Purchase |
2020-10-27 | 13G | Ring Energy, Inc. REI |
Empery Asset Management, LP | 21,428,500 9.990% |
21,428,500 (New Position) |
Filing History |
| 2020-10-15 10:54 am Purchase |
2020-10-09 | 13G | Artelo Biosciences, Inc. ARTL |
Empery Asset Management, LP | 61,333 6.670% |
61,333 (New Position) |
Filing History |
| 2020-10-15 10:53 am Purchase |
2020-10-07 | 13G | enVVeno Medical Corporation HJLI |
Empery Asset Management, LP | 185,864 6.200% |
185,864 (New Position) |
Filing History |
| 2020-10-05 3:20 pm Purchase |
2020-09-30 | 13G | SPI ENERGY CO LTD SHS SPIEF |
Empery Asset Management, LP | 988,000 5.550% |
988,000 (New Position) |
Filing History |
| 2020-10-05 3:17 pm Purchase |
2020-09-30 | 13G | U.S. Energy Corp. USEG |
Empery Asset Management, LP | 157,905 8.940% |
157,905 (New Position) |
Filing History |